The Phase 1 proof-of-concept study analyzed whole genome and limited clinical data from 4,600 GLP-1 RA patients and demonstrated that we can: Identify strong and weak responders based on genetic signatures Quantitatively predict efficacy using BMI and HbA1c change Detect over 2,500 genetic signatures mapping to 1,100 genes Identify 15 major biological mechanisms driving response This is the first time detailed mechanistic efficacy signals have been shown directly within a GLP-1-treated real-world population at this level of resolution
The gradual schedule gives your body time to adapt at each level, making the entire journey more tolerable
Of 133 patients, 27.8% more than one in four had a fasting glucose flagged above range , often before HbA1c moves
This comprehensive review helps ensure that donating plasma won't jeopardize your own health or compromise plasma quality
Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made
Walking, swimming, cycling, yoga, or any activity you enjoy counts